Moreover, miR-200b restrains TNBC migration and metastasis through various mechanisms involving inactivation of EGFR and the downstream PI3K/Akt signaling pathway and suppresses FUT4 expression in cultured breast cancer cell lines [133]. The gene discussed is EGFR; the disease is breast carcinoma.